Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 23:04:53 - browse：67292

Adobe

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States.

Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee. That’s an important development because until now, the House Select Committee on the Chinese Communist Party had handled the bill in the House. That panel is an ad-hoc committee created to build bipartisan consensus on China policies, but it does not have the authority to pass legislation. A Senate committee also passed the BIOSECURE Act nearly unanimously earlier this year.

With the bill out of the Oversight Committee, the goal is for the House to pass it before the July 4 recess. That would set the legislation up to be included in a year-end must-pass legislative package, possibly the National Defense Authorization Act, which Congress has passed every year for decades.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： FTX founder Sam Bankman

WSS

Travel bans should be based on evidence, not politics or fear

Health officials lay out plans to cope with respiratory virus season

Study: Spinal cord stimulation helps patients with paralysis walk again

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Can U.S. cancer drug shortages be fixed?

Meadows told special counsel he could not recall Trump ever declassifying Mar

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

As demand for Covid shots wanes, Moderna seeks its next success

How the first Native Hawaiian psychiatrist helped diversify medicine

Malaria cases in Florida and Texas: Here’s what you need to know

Roche's accidental data boosts hopes for anti

United colonoscopy coverage change 'may cost lives,' doctors say

CDC says it’s too soon to assess risk posed by Covid subvariant

Duchenne breakthrough therapy leaves behind pioneering families

PBMs are inflating the cost of generic drugs. They must be reined in

leisure time

FDA advisory panel to debate high blood pressure devices

Travel bans should be based on evidence, not politics or fear

Judge rejects Trump's counterclaim against E. Jean Carroll

How the drug

FDA advisory panel to debate high blood pressure devices

Study: Spinal cord stimulation helps patients with paralysis walk again

focus

hotspot

leisure time

hotspot